TY  - JOUR

T1  - tAnGo: a randomised phase III trial of gemcitabine in paclitaxel-containing, epirubicin/cyclophosphamide-based, adjuvant chemotherapy for early breast cancer: a prospective pulmonary, cardiac and hepatic function evaluation

JO  - BRIT J CANCER

UR  - http://eprints.whiterose.ac.uk/107805/

PY  - 2008/08/19

AU  - Wardley AM

AU  - Hiller L

AU  - Howard HC

AU  - Dunn JA

AU  - Bowman A

AU  - Coleman RE

AU  - Fernando IN

AU  - Ritchie DM

AU  - Earl HM

AU  - Poole CJ

AU  - tAnGo Trial Collaborators

ED  - 

DO  - DOI: 10.1038/sj.bjc.6604538

VL  - 99

IS  - 4

SP  - 597

EP  - 603

Y2  - 2025/10/10

ER  -